In the Pipeline: Emerging Therapy for MDS and MDS/MPN
H Gill, E Lee, P Mo - Pathogenesis and Treatment of Leukemia, 2023 - Springer
Novel agents in combination with hypomethylating agents are an emerging strategy for
clinical trials in involving higher-risk MDS or MDS/MPN and in patients harbouring high-risk …
clinical trials in involving higher-risk MDS or MDS/MPN and in patients harbouring high-risk …
[图书][B] Pathogenesis and Treatment of Leukemia
H Gill, YL Kwong - 2023 - books.google.com
This book covers a comprehensive update on acute and chronic leukemia. In 54 chapters,
authors introduce research progress and clinical trials of acute myeloid leukaemia (AML) …
authors introduce research progress and clinical trials of acute myeloid leukaemia (AML) …